1. Home
  2. FVRR vs LRMR Comparison

FVRR vs LRMR Comparison

Compare FVRR & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

N/A

Current Price

$7.69

Market Cap

310.6M

ML Signal

N/A

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

N/A

Current Price

$3.31

Market Cap

253.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FVRR
LRMR
Founded
2010
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
310.6M
253.5M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
FVRR
LRMR
Price
$7.69
$3.31
Analyst Decision
Hold
Strong Buy
Analyst Count
10
11
Target Price
$9.42
★ $14.20
AVG Volume (30 Days)
1.0M
★ 1.3M
Earning Date
10-29-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.05
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.57
$1.92
52 Week High
$22.17
$6.42

Technical Indicators

Market Signals
Indicator
FVRR
LRMR
Relative Strength Index (RSI) 38.56 62.96
Support Level N/A $2.89
Resistance Level $9.07 $4.25
Average True Range (ATR) 0.40 0.28
MACD -0.06 0.11
Stochastic Oscillator 7.82 86.70

Price Performance

Historical Comparison
FVRR
LRMR

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

Share on Social Networks: